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Strengths and limitations of this study
 ► To the best of our knowledge this is the first study to 
apply a multivariable risk prediction tool to a popu-
lation in a slum or informal settlement.
 ► We were able to identify cardiovascular disease 
(CVD) deaths of participants occurring in the slum 
during the 10 years after risk prediction.
 ► We were unable to exclude individuals with previous 
myocardial infarction as information was not avail-
able from the survey.
 ► Applying the risk score chart to cross-sectional pop-
ulation data may have underestimated the total CVD 
risk, as data that are required for thorough evalua-
tion of total risk (such as family history) was absent.
AbStrACt
Objectives Although cardiovascular disease (CVD) is of 
growing importance in low- and middle-income countries 
(LMICs), there are conflicting views regarding CVD as a major 
public health problem for the urban poor, including those 
living in slums. We examine multivariable risk prediction in 
a slum population and assess the number of cardiovascular 
related deaths within 10 years of application of the tool.
Setting We use data from the Nairobi Urban Health and 
Demographic Surveillance System (NUHDSS) population 
(residents of two slum communities) between May 2008 and 
April 2009.
Design This is a secondary data analysis from a cross-
sectional survey. We use the WHO/International Society of 
Hypertension (WHO/ISH) cardiovascular risk prediction tool 
to examine 10-year risk of major CVD events in a slum 
population. CVD deaths in the cohort, reported up until 
June 2018 and identified through verbal autopsy are also 
presented.
Participants 3063 men and women aged over 40 years 
with complete data for variables needed for the WHO/ISH risk 
prediction tool were eligible to take part.
results The majority of study members (2895, 94.5%) were 
predicted to have ‘low’ risk (<10%) of a cardiovascular event 
over the next 10 years and just 51 (1.7%) to have ‘high’ CVD 
risk (≥20%). 91 CVD deaths were reported for the cohort 
up until June 2018. Of individuals classified as low risk, 74 
(2.6%) were identified as having died of CVD. Nine (7.7%) 
individuals classified at 10% to 20% risk and eight (15.9%) 
classified at >20% were identified as dying of CVD.
Conclusions This study shows that there is a low risk 
profile of CVD in this slum population in Nairobi, Kenya, 
in comparison to results from application of multivariable 
risk prediction tools in other LMIC populations. This has 
implications for health service planning in these contexts.
IntrODuCtIOn
Non-communicable diseases (NCDs) are 
the leading cause of death globally and have 
become the leading cause of death in low- and 
middle-income countries (LMICs).1 Cardio-
vascular disease (CVD) is a key player in this 
epidemic, accounting for most NCD deaths, 
and studies of CVD in urban areas of LMICs 
have suggested that risk is growing.2–4
A large proportion of the world’s urban 
population live in slums — neighbourhoods 
that are often informal, with poor housing and 
inadequate services.5 There are conflicting 
views regarding CVD as a major public health 
problem for the urban poor, including those 
living in slums. An overview of health in slums 
found no synthesised evidence on CVD prev-
alence or the prevalence of CVD risk factors, 
while primary studies indicated that some CVD 
risk factors appear to be less prevalent among 
those living in slums than in their non-slum 
urban counterparts.5 However, other primary 
studies carried out in urban LMICs have indi-
cated that CVD risk is inversely associated with 
socioeconomic status, or that there is no strong 
socioeconomic gradient, which would suggest 
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that those living in slums had at least equivalent or higher 
risk than other urban residents.6 7
Conventionally, CVD risk prediction focused on the pres-
ence of certain individual risk factors (eg, elevated blood 
pressure or serum cholesterol), however the recognition of 
the multifactorial aetiology of CVD has led to a drastic shift 
away from the single risk factor approach toward a multi-
variable risk prediction approach. Taking into account the 
coexistence of multiple risk factors to determine CVD risk 
has been supported by much research that clearly demon-
strates that the risk of a CVD event can differ among indi-
viduals with the same high levels of single risk factors due 
to the presence or absence of other risk factors.8–10 Further-
more, studies have shown that identifying individuals at 
high CVD risk by adopting a total CVD risk assessment 
approach is more cost-effective method of CVD prevention 
especially in low resource settings.11 12 Determining total 
CVD risk requires risk prediction tools. The WHO/Inter-
national Society of Hypertension (WHO/ISH) developed 
risk score prediction charts for different WHO subregions 
for the purposes of enabling clinicians to quickly assess total 
CVD risk in their patients, but also allow for risk stratifica-
tion of a population in a simple manner.13
However, there are no existing studies that have assessed 
multivariable risk prediction of CVD in a slum popula-
tion. Therefore, the primary aim of this study is to apply 
the WHO/ISH risk prediction tool to a slum population 
in Nairobi, Kenya. In addition, we were able to assess the 
number of cardiovascular-related deaths occurring within 
the slum (but not non-fatal events, or fatal events occurring 
elsewhere) reported within 10 years of application of the 
tool, giving us some idea about the utility of the WHO/
ISH tool in this population, and about the burden of CVD 
within the slum setting. These findings will inform plans for 
health service delivery in the context of urban poor settings.
MethODS
Study population
This study utilises data from a cross-sectional survey 
conducted by the African Population and Health Research 
Center (APHRC) within the Nairobi Urban Health and 
Demographic Surveillance System (NUHDSS) population 
between May 2008 and April 2009. The NUHDSS was setup 
to examine the long-term social, economical and health 
effects of two slum communities within the city of Nairobi, 
Korogocho and Viwandani.14 This population-based survey 
utilised the sampling frame from the NUHDSS and a 
stratified, sampling strategy based on the WHO STEPwise 
protocol with a target of 250 respondents in each of the 
following strata: sex, age group (18 to 24, 25 to 30, 31 to 40, 
41 to 50, 51 to 60 and 60+), and slum of residence (Koro-
gocho and Viwandani). Data were collected from a total of 
5470 individuals aged 18 years and above. Further details 
on the sampling frame and data collection methods are 
published elsewhere.15 Men and women aged over the age 
of 40 years with complete data for variables needed for the 
WHO/ISH risk prediction tool were eligible to take part in 
this secondary data analysis.
ethics
Operations of the NUHDSS are approved by the Govern-
ment of Kenya, and the ethical responsibilities for its oper-
ations overseen by the Kenya Medical Research Institute 
(KEMRI). The CVD study was approved by the Scientific 
and Ethics Review unit of KEMRI (SERU NON-SSC 339). 
Participants were made aware that their participation in the 
study was voluntary, and individual informed consent was 
sought from all participants before their involvement in the 
study.
Study tool
In order to assess the 10-year risk of fatal and non-fatal 
cardiovascular disease (namely myocardial infarction or 
stroke) for each participant in our sample, we used the 
WHO/ISH risk prediction charts for Africa sub-region 
(AFR E).13 The charts are designed for those over 40 and 
those who do not have established coronary heart disease 
(CHD), stroke or other atherosclerotic disease. Therefore, 
our study sample excluded those <40 years of age and those 
with stroke. We were unable to identify and exclude those 
who had established CHD or other atherosclerotic disease 
as the information was not available from the survey.
The chart requires data on sex, age, systolic blood pres-
sure, smoking status and presence or absence of diabetes 
mellitus. If total serum cholesterol is available, this is used 
in CVD risk prediction, however there is also an algorithm 
for use where no total serum cholesterol record is available, 
which we used to calculate risk for the study participants 
with missing cholesterol data. Studies have demonstrated 
high correlation between laboratory-based scores and 
non-laboratory-based scores for men and women.16 17
Following guidelines for using the WHO/ISH risk predic-
tion tool variables were constructed as follows: smokers 
were considered as those who were current smokers at 
assessment or those who quit smoking within the last year 
before the assessment, presence of diabetes was defined 
as someone taking insulin or oral hypoglycaemic drugs 
or having a study-measured fasting glucose >7.0 mmol/L, 
systolic blood pressure was the average of three readings 
on the day of survey while study member was seated using 
OMRON M6 blood pressure machine, total cholesterol 
(mmol/l) was measured by taking capillary blood from 
fingertips using the Accu-Chek Glucose, Cholesterol and 
Triglycerides (GCT) monitors and test strips. The predicted 
risk falls into categories including: from <10% (low), 10 to 
<20% (moderate), 20 to <30% (high), 30 to <40% (very 
high) and 40% or more (highest).18
In addition, practice points accompany the WHO risk 
prediction charts and state that CVD risk may be elevated 
over that specified by the charts when certain factors 
are present. We were able to obtain the following CVD 
enhancing risk factors for our study members: raised 
triglycerides (>2.0 mmol/L), whether on hypertensive 
medication and presence of obesity defined according to 
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body mass index (weight in kg divided by the square of 
height in cm). The prevalence of these CVD risk elevating 
factors were tabulated by the different risk categories.
Identifying cardiovascular related deaths within 10 years of 
application of the tool
To assess the cardiovascular-related deaths among the 
participants of this study, verbal autopsy data present for all 
deaths recorded between 2008 and June 2018 was obtained 
from APHRC. A record linkage was undertaken between 
the cross-sectional survey and the verbal autopsy data using 
a unique identifier present in both data sources.
Verbal autopsy interviews are conducted by experienced 
field interviewers with a ‘credible respondent’, usually a 
family member following identification of deaths during 
regular Demographic Surveillance Site (DSS) data collec-
tion.19 A standardised questionnaire developed in conjunc-
tion with other International Network of Demographic 
Evaluation of Populations and Their Health (INDEPTH) 
sites is used and consists of open and closed questions 
focusing on events leading to the death and specific clinical 
signs and symptoms that the deceased had prior to their 
death. After several visits to a household, if no ‘credible 
respondent’ is identified, verbal autopsy is coded as missing, 
and no cause of death is recorded.
Cause of death is then generated using InterVA-4 software, 
which uses probabilistic models based on Bayes' theorem 
to interpret symptom and signs data from verbal autopsy 
questionnaires and determine possible causes of death. 
Detailed information of the InterVA model and how it was 
developed have been described in previous studies.19–21 
Those with a cardiovascular code recorded under the vari-
able ‘first broad cause of death’ was used to define cardio-
vascular-related death in this study. Cardiovascular death 
included ischaemic heart disease, cerebrovascular disease, 
hypertensive diseases, pulmonary heart disease and diseases 
of pulmonary circulation and diseases of arteries, arterioles 
and capillaries. We additionally examined deaths reported 
due to diabetes mellitus because someone who had diabetes 
at the time of death may have died from a cardiovascular 
outcome, but credible family members may only have 
discussed the condition they were suffering prior to death.
Please note that the deaths recorded in this study were 
deaths only identified during the regular data collec-
tion rounds by the DSS team, it may be that more deaths 
occurred among participants of the original cross-sectional 
survey that were not identified (for example, the partici-
pant had moved before the death took place) and non-fatal 
CVD events were not captured at all. We were not able to 
link individuals in this data set to know if they were still resi-
dent in the NUHDSS in June 2018 — but a larger study 
sample, including this one, identified just 53/4290 (1.2%) 
had exited the NUHDSS between 2008 and 2018 (Frederick 
Wekesah — personal communication). The published rate 
of out migration between 2003 and 2012 was 22.5%.14 For 
these reasons we can’t be sure how well the tool predicted 
CVD events in this population but include these figures to 
add to knowledge about the burden of disease and give 
some indication of the tool’s performance.
Patients and public were not involved in this study.
Statistical analyses
Data analysis was conducted in Stata, V.14.0 (StataCorp 
LP, College Station, USA). Percentages were calculated for 
categorical variables. Sampling weights were applied where 
noted.
reSultS
Description of sample
Of the 5470 survey participants, 2316 were excluded due 
to age (<40 years). Of the remaining 3154 participants 
aged over 40, 10 were excluded due to having a stroke. 
Eighty-one (2.6%) were excluded due to incomplete data 
for the variables required of the WHO/ISH risk prediction 
tool (missing data for smoking status (n=2) and for blood 
pressure (n=81)).
Characteristics of the 3063 participants included in the 
final sample are represented in table 1. The majority of 
participants included in the analyses were male (57.6%) 
and were between 40 to 60 years old, 88% of participants 
included in the analyses were non-smokers, 3% had diabetes 
and approximately 24% had blood pressure ≥140 mm Hg.
Population distribution of CVD risk using WhO/ISh risk 
prediction chart and prevalence of CVD risk-enhancing factors
The majority of participants in this study sample had low 
(<10%) total 10 year CVD risk (2895, 94.5%) [table 2]. 
That is, they had less than 10% predicted chance of a fatal 
or non-fatal CVD event over the following 10 years. When 
CVD-risk enhancing factors were taken into account, 1963 
participants (64.1%) had low (<10%) total 10 year CVD risk 
with no additional risk enhancing factors. In the weighted 
analysis, the percentage of people in the <10% risk group 
was 96.3% with the reduced risk profile due to correction 
of the over-sampling of older age groups. After applying the 
CVD-enhancing factors, the percentage of people in the 
<10% risk group reduced to 63.7% in the weighted analysis.
WHO also states risk from prediction charts alone can 
underestimate the risk in those with high blood pressure 
(≥160/100) or blood cholesterol ≥8. In our sample, 9.83% 
had raised blood pressure but only 0.07% of those who 
had a cholesterol blood test were raised above the speci-
fied level. Of those at <10% risk group, 131 participants had 
raised blood pressure above or equal to 160/100 and of 
those in this category that had a blood cholesterol test only 
two participants had a blood cholesterol ≥8.
Cardiovascular related-deaths at different levels of predicted 
CVD risk based on chart alone
Following record linkage of verbal autopsy database and 
the respondents of the cross-sectional survey, 466 records 
were matched: that is 466 of the original cohort had a 
death reported up to June 2018 among the participants 
from the cross-sectional survey (n=5470). Among the 
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Table 1 Characteristics of study participants
Total (n=3063) Men (n=1765) Women (n=1298)
Age in years (n, %)
  40–49 1168 (38.13) 595 (33.71) 573 (44.14)
  50–59 1169 (38.17) 770 (43.63) 399 (30.74)
  60–69 493 (16.10) 294 (16.66) 199 (15.33)
  ≥70 233 (7.61) 106 (6.01) 127 (9.78)
BMI category (n, %)*
  <30 kg/m2 2714 (89.39) 1700 (96.98) 1014 (79.03)
  ≥30 kg/m2 322 (10.61) 53 (3.02) 269 (20.97)
Smoking status (n, %)
  Current 375 (12.24) 364 (20.62) 11 (0.85)
  Non-smoker 2688 (87.76) 1401 (79.38) 1287 (99.15)
Blood pressure (n, %)
  <140 2312 (75.48) 1382 (78.30) 939 (72.34)
  140–159 441 (14.40) 237 (13.43) 204 (15.72)
  160–179 185 (6.04) 101 (5.72) 84 (6.47)
  180+ 116 (3.79) 45 (2.55) 71 (5.47)
Diabetes (n, %)
  Absent 2976 (97.16) 1727 (97.85) 1249 (96.22)
  Present 87 (2.84) 38 (2.15) 49 (3.78)
Total cholesterol (n, %)
  <5 2220 (72.48) 1307 (74.05) 913 (70.33)
  5–5.9 516 (16.84) 281 (15.92) 235 (18.10)
  6–6.9 74 (2.42) 32 (1.81) 42 (3.24)
  7–7.9 10 (0.33) 5 (0.28) 5 (0.39)
  8+ 2 (0.07) 1 (0.06) 1 (0.08)
  Cholesterol missing 241 (7.87) 139 (7.88) 102 (7.86)
*Realistic BMI values only available for 3036 participants of our total sample size of 3063.
BMI, body mass index.
3063 participants included in this study, 410 deaths were 
recorded with 91 deaths specifically related to CVD (3% 
of the study population), while 34 were classified as inde-
terminate and in 34 further cases, a verbal autopsy was 
not performed. Cardiovascular related cause of death was 
assigned to 74 (2.6%) of individuals classified as low risk 
(<10% predicted chance of a fatal or non-fatal CVD event). 
Nine (7.7%) of individuals classified at 10% to 20% risk of a 
fatal or non-fatal CVD event were determined to have died 
from CVD, and eight (15.9%) of those at high risk (≥20%) 
(table 3). Out of 336 deaths in <10% group, 87 individuals 
who had died had one or more CVD-enhancing factors, 18 
of these deaths were due to CVD risk and 2 deaths were due 
to diabetes.
DISCuSSIOn
Of the 3063 study members aged over 40, the majority 
(94.5%) were predicted to have a less than 10% chance of 
experiencing a cardiovascular event over the next 10 years 
and just 1.7% having a ‘high’ CVD risk (≥20%). When 
weighted to be representative of all adults aged over 40 
living in the slum 96.3% were predicted to fall in the lowest 
risk group and just 1.2% have a ‘high’ CVD risk (≥20%). 
This is a low risk population profile in comparison to results 
from application of the multivariable risk prediction tools 
in other populations. Studies conducted specifically among 
urban dwellers in LMIC countries such as Malaysia22 and 
Sri Lanka23 have found 20.5% and 8.2% individuals were 
at high risk (≥20%) of having a future CVD event, respec-
tively. Furthermore, the proportion of individuals in our 
study shown to be at low risk of a CVD event over 10 years 
(<10% risk) was higher than that of studies who used the 
WHO/ISH risk prediction charts carried out in rural Nepal 
(86.4%),24 rural South India (83%)25 and rural Bangladesh 
(81.3%).26 Mendis et al reported total 10 year CVD risk in 
defined geographical areas of seven countries including 
both urban and rural populations, but only two coun-
tries had a higher percentage of individuals classified as 
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Table 3 Total deaths and deaths due to cardiovascular disease recorded up to June 2018 at different levels of predicted CVD 
risk (based on chart alone)
10-year CVD risk
<10%
Low
10%–20%
Moderate
20%–30%
High risk
30%–40%
Very high risk
≥40%
Highest risk
Total
Deaths recorded (n, %) 336 (11.6) 25 (21.4) 11 (35.5) 7 (50.0) 1 (16.7)
Broad first cause of death: cardiovascular (n, 
%)
74 (2.6) 9 (7.7) 5 (16.1) 2 (14.3) 1 (16.7)
Broad first cause of death: diabetes Mellitus 
(n, %)
8 (0.3) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Indeterminate cause (n, %) 30 (1.0) 4 (3.4) 0 (0.0) 0 (0.0) 0 (0.0)
VA not done (n, %) 33 (1.1) 1 (0.9) 0 (0.0) 0 (0.0) 0 (0.0)
Male
Deaths recorded (n, %) 199 (11.9) 10 (16.9) 5 (41.7) 4 (36.4) 0 (0.0)
Broad first cause of death: cardiovascular (n, 
%)
35 (2.1) 3 (5.1) 2 (16.7) 1 (9.1) 0 (0.0)
Broad first cause of death: diabetes Mellitus 
(n, %)
3 (0.2) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Indeterminate cause (n, %) 16 (1.0) 1 (1.7) 0 (0.0) 0 (0.0) 0 (0.0)
VA not done (n, %) 22 (1.3) 1 (1.7) 0 (0.0) 0 (0.0) 0 (0.0)
Female
Deaths recorded (n, %) 137 (11.3) 15 (25.9) 6 (31.6) 3 (100) 1 (50.0)
Broad first cause of death: cardiovascular (n, 
%)
36 (3.1) 6 (10.3) 3 (15.8) 1 (33.3) 1 (50.0)
Broad first cause of death: diabetes mellitus 
(n, %)
5 (0.4) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Indeterminate cause (n, %) 141 (11.6) 3 (5.2) 0 (0.0) 0 (0.0) 0 (0.0)
VA not done (n, %) 11 (0.9) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
CVD, cardiovascular disease; VA, verbal autopsy.
low risk in comparison to our study (lower: Iran (93.9%), 
Cuba (89.7%), Nigeria (86.0%), Georgia (83.1%), Pakistan 
(79.2%); similar: China (96.1%) and Sri Lanka (94.9%)).12 
However, it is important to note, the proportion of individ-
uals estimated to have low (<10%) total CVD risk substan-
tially decreased in our study, when risk-elevating factors 
stated in practice points accompanying WHO/ISH charts 
(raised triglycerides, obesity and anti-hypertensive medi-
cation) were added to the CVD risk assessment of the 
population.
CVD deaths occurring in our study population within 
the slum, reflected risk-categories assigned by the WHO/
ISH tool (bearing in mind that additional deaths may have 
occurred in study members outside the slum and that 
non-fatal events were not recorded). Taken as a whole, it 
appears from this data that health services geared towards 
CVD treatment may be less of a priority in slum settings 
in Kenya, or potentially in sub-Saharan Africa, than in the 
wider urban areas of LMIC cities. An important reason 
for this may be the age-structure of the slum population, 
which is very young. However, given the large percentage of 
CVD-enhancing factors in this population, it could be that 
the future burden (when this population gets older) will be 
significant. The signal here could be that CVD prevention 
is more of a priority here than treatment.
Certain limitations of this work need to be considered 
when interpreting the findings. First, we were unable to 
exclude individuals with previous myocardial infarction as 
information was not available from the survey. However, if 
we failed to identify significant numbers with a previous 
myocardial infarction, the remaining population (once 
these individuals had been excluded) would have likely had 
an even more extremely low risk profile for CVD. Second, 
applying the risk score chart to cross-sectional population 
data may have underestimated the total CVD risk, as data 
that are required for thorough evaluation of total risk such 
as family history or even history of relevant current diseases 
(the obvious example being myocardial infarction) and 
treatments, were not present in the data. Third, there are 
some deviations in our methods from the instructions of 
how the WHO/ISH charts should be used: systolic blood 
pressure was measured three times on 1 day, rather than 
twice at two different time points, which could increase 
the risk that some of the participants experienced white-
coat hypertension; we defined someone as having diabetes 
if they were taking insulin or oral hypoglycaemic drugs or 
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if their fasting plasma glucose concentration was about 
7.0 mmol/L on one occasion (not on two separate occa-
sions as recommended). Finally, where we used cholesterol 
readings — these were also from one time point, rather 
than two as recommended.
Finally, it is a regret that we don’t have data on all possible 
fatal CVD events (for example in those who have moved 
from the study site and are therefore not followed up in 
the NUHDSS) or non-fatal events that have occurred in the 
10 years since the risk data was collected in order to validate 
the WHO/ISH tool in this setting.
Despite these limitations, our study uses rare data to 
provide a good estimate of total 10 year CVD risk among 
a marginalised population in an urban poor setting in 
sub-Saharan Africa. To the best of our knowledge this is the 
first study to apply a multivariable risk prediction tool to a 
population in a slum or informal settlement and to assess 
the number of cardiovascular related deaths within 10 years 
of application of the tool. This study shows that there is a 
low risk profile of CVD in this slum population in Nairobi, 
Kenya, and that the WHO/ISH tool does differentiate 
groups at increasing risk of CVD mortality. This has impli-
cations for planning of health service delivery in slums.
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